BGM Group Ltd.

US$8.25As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:BGMHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (7.41%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 1.46
PE TTM —
TSR TTM (97.09%)
Mkt cap US$110.2M
ROIC (2.39%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$9.92
20.24%
(37.46%)
Hold 3|11|12|2|0
1Q26
2Q26
3Q26
4Q26
Earnings per share$
0.09
0.10
0.10
0.10
16.48%
19.14%
8.98%
19.52%
Revenue$M
7.407
7.459
7.725
7.926
2.36%
2.34%
4.10%
6.03%
Peers (US$110.2M)
Cap (US$)
PE
110.2M
—
Capital
TTM
5Y
10Y
Leveragex
0.549
(0.081)
(0.082)
EBIT/Intx
0.531
0.923
0.724
Own earn%
121.98
(6.52)
(7.38)
Sh yield%
17.34
59.43
54.41
Owners
Insiders/Inst%
1.91
58.66
Short interest%
4.10
SBC / revenue%
1.36
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
23–28
$1 testx
—
Incr. ROIC%
5